Literature DB >> 6232888

The efficacy of agents employed to prevent anastomotic recurrence in colorectal carcinoma.

H C Umpleby, R C Williamson.   

Abstract

Forty-eight of 72 surgeons canvassed in the South West of England (67%) routinely use an intraluminal cytotoxic agent to prevent suture-line recurrence following partial resection of the large bowel for cancer. The most popular agents are chlorhexidine-cetrimide preparations (n = 14), mercuric perchloride (12), povidone-iodine (7) and water (12); noxythiolin, sodium hypochlorite and silver nitrate are used occasionally. The mean duration of treatment is 2 minutes. When assayed for cytotoxity against tumour cells freshly prepared from human colorectal carcinomas (n = 10), both chlorhexidine-cetrimide and povidone-iodine were rapidly lethal at a wide range of concentrations (5-100%). Mercuric perchloride (0.2%) was similarly effective, but up to 20% of tumour cells remained viable after exposure to noxythiolin and nearly 30% with water alone. Chlorhexidine-cetrimide and povidone-iodine are the agents of choice to kill malignant cells exfoliated into the colorectal lumen.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6232888      PMCID: PMC2492522     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  9 in total

1.  ANAL METASTASES FROM CARCINOMA OF THE RECTUM AND COLON.

Authors:  M KILLINGBACK; E WILSON; E S HUGHES
Journal:  Aust N Z J Surg       Date:  1965-02

2.  Implantation from the bowel lumen in cancer of the large intestine.

Authors:  W M KEYNES
Journal:  Ann Surg       Date:  1961-03       Impact factor: 12.969

3.  Trends in the treatment of tumours of the rectum, rectosigmoid and left colon.

Authors:  C N MORGAN
Journal:  J R Coll Surg Edinb       Date:  1955-12

4.  Experimental use of cetrimide in the prevention of wound implantation with cancer cells.

Authors:  G R Gibson; F O Stephens
Journal:  Lancet       Date:  1966-09-24       Impact factor: 79.321

5.  Inhibition of the growth of tumour cells in culture by noxytiolin.

Authors:  C W Jamieson
Journal:  Br J Surg       Date:  1972-02       Impact factor: 6.939

6.  Intraperitoneal noxytiolin as an experimental chemotherapeutic agent.

Authors:  S Desai; C W Jamieson
Journal:  Br J Surg       Date:  1973-05       Impact factor: 6.939

7.  Pathogenesis of recurrences on the suture line following surgical resection for carcinoma of the colon.

Authors:  G Gricouroff
Journal:  Cancer       Date:  1967-05       Impact factor: 6.860

8.  The aetiology of colonic suture-line recurrence.

Authors:  I L Rosenberg
Journal:  Ann R Coll Surg Engl       Date:  1979-07       Impact factor: 1.891

9.  Cell viability studies on the exfoliated colonic cancer cell.

Authors:  I L Rosenberg; C W Russell; G R Giles
Journal:  Br J Surg       Date:  1978-03       Impact factor: 6.939

  9 in total
  18 in total

1.  Cetrimide lavage: ineffective and potentially toxic.

Authors:  W R Saeed; J Stewart; E A Benson
Journal:  Ann R Coll Surg Engl       Date:  1991-01       Impact factor: 1.891

2.  The effect of rectal washout on local recurrence following rectal cancer surgery.

Authors:  S R Moosvi; K Manley; J Hernon
Journal:  Ann R Coll Surg Engl       Date:  2017-11-28       Impact factor: 1.891

3.  Enhanced growth of tumour cells in healing colonic anastomoses and laparotomy wounds.

Authors:  D Skipper; M J Jeffrey; A J Cooper; P Alexander; I Taylor
Journal:  Int J Colorectal Dis       Date:  1989-08       Impact factor: 2.571

Review 4.  Anastomotic recurrence of colorectal cancer--a biological phenomenon or an avoidable calamity?

Authors:  M R Keighley; C Hall
Journal:  Gut       Date:  1987-07       Impact factor: 23.059

Review 5.  [Radical surgery and/or continence preservation in rectal cancer].

Authors:  F W Eigler; S Luetkens
Journal:  Langenbecks Arch Chir       Date:  1987

6.  A prospective clinical study assessing the presence of exfoliated cancer cells and rectal washout including tumors in patients who receive neoadjuvant chemoradiotherapy for rectal cancer.

Authors:  Kazutake Okada; Sotaro Sadahiro; Yutaro Kamei; Lin Fung Chan; Takashi Ogimi; Hiroshi Miyakita; Gota Saito; Akira Tanaka; Toshiyuki Suzuki
Journal:  Surg Today       Date:  2019-10-21       Impact factor: 2.549

7.  Antiseptic toxicity to breast carcinoma in tissue culture: an adjuvant to conservation therapy?

Authors:  M E Lucarotti; H White; J Deas; I A Silver; D J Leaper
Journal:  Ann R Coll Surg Engl       Date:  1990-11       Impact factor: 1.891

8.  Antineoplastic activity of povidone-iodine on different mesothelioma cell lines: results of in vitro study.

Authors:  Alfonso Fiorelli; Francesca Pentimalli; Vittorio D'Urso; Domenico Di Marzo; Iris Maria Forte; Antonio Giordano; Marina Di Domenico; Marina Accardo; Umberto Di Serio; Mario Santini
Journal:  Eur J Cardiothorac Surg       Date:  2014-01-06       Impact factor: 4.191

9.  Cutaneous perianal recurrence of cancer after anterior resection using the EEA stapling device.

Authors:  D J De Friend; E Kramer; R Prescott; J Corson; P Gallagher
Journal:  Ann R Coll Surg Engl       Date:  1992-03       Impact factor: 1.891

10.  Evaluation of the presence of intraluminal cancer cells following rectal washout in rectal cancer surgery.

Authors:  G Dafnis; M Nordstrom
Journal:  Tech Coloproctol       Date:  2013-05-30       Impact factor: 3.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.